Special Investigation Of Azithromycin IV For Legionnaires' Disease (Regulatory Post Marketing Commitment Plan)
NCT01784770
·
clinicaltrials.gov ↗
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
Legionnaires' Disease
Legionella Pneumophila Infections
Interventions
DRUG:
Azithromycin IV
Sponsor
Pfizer